Skip to main content
Bulletin of the New York Academy of Medicine logoLink to Bulletin of the New York Academy of Medicine
. 1966 Nov;42(11):1023–1036.

Circulatory effects of vasoactive drugs in current use for treatment of shock. A reclassification based on experimental and clinical study of their selective arterial and venous effects.

M H Weil, E C Bradley
PMCID: PMC1806523  PMID: 5232122

Full text

PDF
1023

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AVIADO D. M. PHARMACOLOGIC APPROACH TO THE TREATMENT OF SHOCK. Ann Intern Med. 1965 May;62:1050–1059. doi: 10.7326/0003-4819-62-5-1050. [DOI] [PubMed] [Google Scholar]
  2. DUFF J. H., MALAVE G., PERETZ D. I., SCOTT H. M., MACLEAN L. D. THE HEMODYNAMICS OF SEPTIC SHOCK IN MAN AND IN THE DOG. Surgery. 1965 Jul;58:174–184. [PubMed] [Google Scholar]
  3. MACLEAN L. D., SPINK W. W., VISSCHER M. B., WEIL M. H. Studies on the circulatory changes in the dog produced by endotoxin from gram-negative microorganisms. J Clin Invest. 1956 Nov;35(11):1191–1198. doi: 10.1172/JCI103373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. UDHOJI V. N., WEIL M. H. CIRCULATORY EFFECTS OF ANGIOTENSIN, LEVARTERENOL AND METARAMINOL IN THE TREATMENT OF SHOCK. N Engl J Med. 1964 Mar 5;270:501–505. doi: 10.1056/NEJM196403052701004. [DOI] [PubMed] [Google Scholar]
  5. Udhoji V. N., Weil M. H. Vasodilator action of a "pressor amine," mephentermine (Wyamine), in circulatory shock. Am J Cardiol. 1965 Dec;16(6):841–846. doi: 10.1016/0002-9149(65)90702-2. [DOI] [PubMed] [Google Scholar]
  6. Vick J. A., Ciuchta H. P., Manthei J. H. Use of isoproterenol and phenoxybenzamine in treatment of endotoxin shock. J Pharmacol Exp Ther. 1965 Dec;150(3):382–388. [PubMed] [Google Scholar]

Articles from Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES